Buy Affimed Stock | AFMD Stock Price & Latest News | Public.com
AFMD

Affimed

$0.00 (0.00%)Today
    View Affimed (AFMD) stock trends here

    About AFMD

    Affimed NV engages in discovering and developing of targeted cancer immunotherapies. Its pipelines include Innate Cell Engagers and T Cell Engagers. The company was founded in 2000 and is headquartered in Heidelberg, Germany. The full company name is Affimed NV....

    Buy any stock with any amount of money.

    Download the App
    Download the app

    What Wall Street Thinks

    Events

    List of events that could affect this stock.

    Earnings

    The value each share was expected to gain vs. the value that each share actually gained

    0
    -0.06
    -0.13
    -0.19
    Q2 2020
    Q3 2020
    Q4 2020
    Q1 2021

    Expected EPS
    Q1 2021

    -$0.14

    Actual EPS
    Q1 2021

    Stats

    Market Cap$693,16M
    Volume647,76k
    Price-to-Earnings Ratio
    Dividend Rate
    Dividend Yield
    1 Year High$7.48
    1 Year Low$1.42
    Open$5.93
    High$5.96
    Low$5.66

    Buy any stock with any amount of money.

    Download the App
    Download the app